- US-listed companies
- Novo Integrated Sciences, Inc.
- Income statement
Novo Integrated Sciences, Inc. (NVOS) Income statement
Market cap
$76.95K
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/08 | 2018/08 | 2019/08 | 2020/08 | 2021/08 | 2022/08 | 2023/08 | 2024/08 | |
| Revenue | - | - | - | - | - | - | 8 | 9 | 9 | 8 | 9 | 12 | 13 | 13 |
| Revenue growth (%) | - | - | - | - | - | - | - | |||||||
| Cost of revenue | - | - | - | - | - | - | 5 | 5 | 6 | 5 | 5 | 7 | 8 | 8 |
| Gross profit | - | - | - | - | - | - | 3 | 3 | 4 | 3 | 4 | 5 | 5 | 6 |
| Gross margin (%) | - | - | - | - | - | - | ||||||||
| Research & development | 4 | 4 | 4 | - | - | - | - | - | - | - | - | - | - | - |
| Operating margin (%) | - | - | - | - | - | - | ||||||||
| Operating expenses | - | - | - | - | - | - | 3 | 5 | 4 | 7 | 8 | 30 | 14 | 16 |
| Operating income | - | - | - | - | - | - | -113,044 | -1,569,428 | -785,597 | -4,262,598 | -4,373,519 | -25,026,677 | -8,553,162 | -10,076,298 |
| Income before tax | - | - | - | - | - | - | -633,562 | -2,117,193 | -403,579 | -4,924,209 | -4,470,935 | -33,067,480 | -13,269,444 | -16,128,570 |
| Pretax margin (%) | - | - | - | - | - | - | -8 | -23.8 | -4.3 | -62.6 | -48 | -281.7 | -105.5 | -121.3 |
| Provision for income taxes | - | - | - | - | - | - | -111,702 | - | - | - | - | -22,302 | - | - |
| Effective tax rate (%) | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Net income | -2,238,011 | -1,160,250 | -887,672 | -1,033,532 | -2,770,714 | -164,887 | -738,384 | -2,108,012 | -391,984 | -4,915,154 | -4,462,147 | -32,849,215 | -13,214,552 | -16,128,570 |
| Net income margin (%) | - | - | - | - | - | - | ||||||||
| Earnings per share | -0.04 | -0.02 | -0.01 | - | - | - | - | - | - | - | - | -1.13 | -1.3 | -0.89 |
| Diluted EPS | -0.04 | -0.02 | -0.01 | - | - | - | - | - | - | - | - | -1.13 | -1.3 | -0.89 |